← Leaderboards
Keith A Hruska
Barnes-Jewish Hospital
$12,070,993
Attributed
$12,168,247
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $701.7K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,168,247 · 13
By mechanism
R01$10,482,771 · 7
P01$805,268 · 2
T32$581,491 · 1
R41$194,509 · 1
R56$76,208 · 1
R13$28,000 · 1
Top collaborators
- Deanna J. Nelson1 shared
Others in their field
Top investigators on “Osteoblasts”
- Gerard Karsenty · University Of Texas Md Anderson Can Ctr$29,617,439
- Clifford J Rosen · Icahn School Of Medicine At Mount Sinai$20,700,088
- Henry M Kronenberg · Massachusetts General Hospital$20,551,682
- Brendan Hl Lee · Baylor College Of Medicine$20,273,696
- Stavroula Kousteni · Columbia University Health Sciences$19,552,379
- Ernesto Canalis · University Of Connecticut Sch Of Med/Dnt$18,574,878
Research focus
OsteoblastsBone DiseasesKidney DiseasesVascular CalcificationInorganic PhosphateKidneyTranscription FactorRenal OsteodystrophyCalcitriolCardiovascular SystemChronic Kidney FailurePreventOsteogenesisPhosphorusSkeletonProductionGeneral PopulationMorbidity - Disease RateFunctional DisorderBlood VesselsMineralsCardiovascular DiseasesPandemic DiseasePathogenesis
Grant awards (48)
Novel Advances in the Pathophysiology and Treatment of the CKD-MBD$408,840
R01 · FY2024 · DK · contact PI
Novel Advances in the Pathophysiology and Treatment of the CKD-MBD$425,874
R01 · FY2023 · DK · contact PI
Novel Advances in the Pathophysiology and Treatment of the CKD-MBD$425,874
R01 · FY2022 · DK · contact PI
Novel Advances in the Pathophysiology and Treatment of the CKD-MBD$425,874
R01 · FY2021 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$343,125
R01 · FY2018 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$343,125
R01 · FY2017 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$343,125
R01 · FY2016 · DK · contact PI
CARDIOVASCULAR RISK MECHANISMS IN CKD$330,600
R01 · FY2016 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$343,125
R01 · FY2015 · DK · contact PI
CARDIOVASCULAR RISK MECHANISMS IN CKD$330,600
R01 · FY2015 · DK · contact PI
ASBMR Symposium - Crosstalk Between Kidney and Bone: Bench to Bedside$28,000
R13 · FY2015 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$343,125
R01 · FY2014 · DK · contact PI
CARDIOVASCULAR RISK MECHANISMS IN CKD$330,600
R01 · FY2014 · DK · contact PI
CARDIOVASCULAR RISK MECHANISMS IN CKD$319,030
R01 · FY2013 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$220,020
R01 · FY2013 · DK · contact PI
CARDIOVASCULAR RISK MECHANISMS IN CKD$330,600
R01 · FY2012 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$228,000
R01 · FY2012 · DK · contact PI
RENAL OSTEODYSTROPHY AND VASCULAR CALCIFICATION$228,000
R01 · FY2011 · DK · contact PI
Renal Osteodystrophy and Vascular Calcification$293,547
R01 · FY2010 · DK · contact PI
Novel Phosphate Binder: Effects on Hyperphosphatemia, Vascular Calcification & Bo$194,509
R41 · FY2010 · DK
Renal Osteodystrophy and Vascular Calcification$296,512
R01 · FY2009 · DK · contact PI
Renal Osteodystrophy and Vascular Calcification$296,512
R01 · FY2008 · DK · contact PI
Pediatric Training Program in Chronic Kidney Diseases$57,998
T32 · FY2008 · DK · contact PI
Renal Osteodystrophy and Vascular Calcification$303,144
R01 · FY2007 · DK · contact PI
Pediatric Training Program in Chronic Kidney Diseases$106,964
T32 · FY2007 · DK · contact PI
Renal Osteodystrophy and Vascular Calcification$313,223
R01 · FY2006 · DK · contact PI
Pediatric Training Program in Chronic Kidney Diseases$113,656
T32 · FY2006 · DK · contact PI
The Role of BMP-7 in Chronic Kidney Disease$76,208
R56 · FY2006 · DK · contact PI
The Role of BMP-7 in Chronic Kidney Disease$320,406
R01 · FY2005 · DK
Pediatric Training Program in Chronic Kidney Diseases$71,296
T32 · FY2005 · DK
The Role of BMP-7 in Chronic Kidney Disease$320,406
R01 · FY2004 · DK
MATRIX PROTEIN/INTEGRIN MEDIATED OSTEOCLAST REGULATION$296,820
R01 · FY2004 · AR
Pediatric Training Program in Chronic Kidney Diseases$114,787
T32 · FY2004 · DK
The Role of BMP-7 in Chronic Kidney Disease$320,406
R01 · FY2003 · DK
MATRIX PROTEIN/INTEGRIN MEDIATED OSTEOCLAST REGULATION$296,820
R01 · FY2003 · AR
Pediatric Training Program in Chronic Kidney Diseases$116,790
T32 · FY2003 · DK
The Role of BMP-7 in Chronic Kidney Disease$383,299
R01 · FY2002 · DK
MATRIX PROTEIN/INTEGRIN MEDIATED OSTEOCLAST REGULATION$194,595
R01 · FY2002 · AR
MOTILITY FACTORS IN RENAL FIBROGENESIS$186,476
P01 · FY2002 · DK
MATRIX PROTEIN/INTEGRIN MEDIATED OSTEOCLAST REGULATION$92,525
R01 · FY2002 · AR
MATRIX PROTEIN/INTEGRIN MEDIATED OSTEOCLAST REGULATION$287,120
R01 · FY2001 · AR
MOTILITY FACTORS IN RENAL FIBROGENESIS$186,476
P01 · FY2001 · DK
CELL MATRIX RESPONSE TO MECHANICAL LOADING$0
P01 · FY2001 · AR
MATRIX PROTEIN/INTEGRIN MEDIATED OSTEOCLAST REGULATION$287,120
R01 · FY2000 · AR
CELL MATRIX RESPONSE TO MECHANICAL LOADING$245,840
P01 · FY2000 · AR
REGULATION OF BONE CELL FUNCTION$242,282
R01 · FY2000 · AR
MECHANISM OF NON-GENOMIC ACTION OF VITAMIN D$218,497
R01 · FY2000 · DK
MOTILITY FACTORS IN RENAL FIBROGENESIS$186,476
P01 · FY2000 · DK